Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-025792

President and CEO sold 25,000 shares at an average $53.54 ($1,338,559)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Campbell David Alan · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-28 Sale : show line 1 in the form 10b5-1 −13,897 $53.22 $739,650 293,157 D
2024-10-28 Sale : show line 2 in the form 10b5-1 −11,103 $53.94 $598,909 282,054 D
Open-market sales · 25,000 sh · avg $53.54 · $1,338,559
Loading xslF345X05/form4-10302024_071002.xml…